Scarica l'app Stockscreener
1.20
0.84%
0.01
Dopo l'orario di chiusura:
1.19
-0.01
-0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BNGO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.19
Aprire:
$1.18
Volume 24 ore:
118.77K
Relative Volume:
0.37
Capitalizzazione di mercato:
$13.31M
Reddito:
$28.51M
Utile/perdita netta:
$-26.40M
Rapporto P/E:
-0.2192
EPS:
-5.4756
Flusso di cassa netto:
$-16.35M
1 W Prestazione:
+4.35%
1M Prestazione:
+5.26%
6M Prestazione:
-36.51%
1 anno Prestazione:
-68.00%
Intervallo 1D:
$1.17
$1.22
Intervallo di 1 settimana:
$1.09
$1.22
Portata 52W:
$1.06
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
Nome
Bionano Genomics Inc
Settore
Industria
Telefono
(858) 888-7600
Indirizzo
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.20 | 13.31M | 28.51M | -26.40M | -16.35M | -5.4756 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-12 | Ripresa | BTIG Research | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2021-06-16 | Iniziato | BTIG Research | Buy |
| 2020-09-24 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-08 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bionano Genomics, Inc. (BNGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] Bionano Genomics, Inc. SEC Filing - Stock Titan
Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes - Stock Titan
Aug Highlights: Is Bionano Genomics Inc benefiting from interest rate changes2026 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - Bitget
In 211 myeloma samples, OGM found abnormalities older tests missed - Stock Titan
BNGO Stock Price, Quote & Chart | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Q4 2024 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Volume Summary: Is Bionano Genomics Inc backed by strong institutional buying2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Profit Review: Is Bionano Genomics Inc part of any ETFWeekly Trade Recap & High Accuracy Buy Signal Tips - baoquankhu1.vn
Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN
Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - Minichart
Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054 - Minichart
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip - Investing.com Canada
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Earnings Call Summary | Bionano Genomics(BNGO.US) Q4 2025 Earnings Conference - Moomoo
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bionano Genomics (BNGO) Reports Q4 2025 Earnings, Sets 2026 Reve - GuruFocus
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Bionano Genomics (BNGO) Earnings Transcript - AOL.com
Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges By Investing.com - Investing.com South Africa
Bionano Genomics (BNGO) Sees Promising Growth in Optical Genome Mapping - gurufocus.com
Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges - Investing.com
Bionano Genomics (BNGO) Reports Q4 Revenue Beat Despite Lower Sa - GuruFocus
Bionano Genomics Inc (BNGO) DEC/2025 Earning Prediction - Intellectia AI
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga
BNGO Projects Revenue Growth for FY26 - GuruFocus
Bionano Genomics shares are trading higher af... - benzinga.com
Bionano Genomics 2025 10-K: Revenue $28.5M, EPS $(4.85) - TradingView
Bionano Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Going-concern risk and OGM growth focus at Bionano Genomics (NASDAQ: BNGO) - Stock Titan
Bionano Genomics Sees FY2026 Sales $30.000M-$33.000M vs $35.075M EstBionano Genomics (NASDAQ:BNGO) - benzinga.com
BRIEF-Bionano Genomics Q4 Revenue USD 8 Million - TradingView
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 - GlobeNewswire
[8-K] Bionano Genomics, Inc. Reports Material Event - Stock Titan
Bionano Genomics Surges 21.7% on Strong Technical Signals and Pre-Earnings Optimism – What’s Next for BNGO? - Bitget
BNGO: 2025 revenue fell 7% to $28.5M; net loss narrowed to $26.4M, but liquidity risks persist - TradingView
United Airlines, AGI And 3 Stocks To Watch Heading Into Monday - Benzinga
Bionano Genomics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Bionano Genomics, Inc. (BNGO) - Minichart
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
Bionano Genomics Inc (BNGO) Stock Price, Quote, News & History - Benzinga
Bionano Genomics Inc expected to post a loss of $1.40 a shareEarnings Preview - TradingView
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):